Comparative efficacy and safety of imrecoxib versus celecoxib: a systematic review and meta-analysis

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-01-05
DOI
https://doi.org/10.3389/fphar.2025.1707079
Primary Topic
Spondyloarthritis Studies and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparative efficacy and safety of imrecoxib versus celecoxib: a systematic review and meta-analysis

Lilin Dai, Zengzhen Liao, Zude Li, Xian Zeng et al.
Frontiers in Pharmacology
Spondyloarthritis Studies and Treatments
article

Comparative efficacy and safety of imrecoxib versus celecoxib: a systematic review and meta-analysis

Lilin Dai, Zengzhen Liao, Zude Li, Xian Zeng, Liji Chen, Yuan Tan, Wei Chen, Xiaomin Dong
article en

Abstract

No abstract available for this paper.
Frontiers in PharmacologyVol. 16
Guilin Medical University (CN), Guilin University of Aerospace Technology (CN), Guilin University of Technology (CN), Guilin University of Electronic Technology (CN)
Good health and well-being
Openalex Percentile: Top 98%
Spondyloarthritis Studies and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.